Compugen Ltd

Uždarymo kaina

2.27 7.08

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.23

Max

2.2800000000000002

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

5.5

56.269

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+104.82% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-73M

198M

Ankstesnė atidarymo kaina

-4.81

Ankstesnė uždarymo kaina

2.27

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-02 23:56; UTC

Macro News

FTSE 100 Index rises in after-market hours as inflation concerns ease. Positive corporate news and U.S. employment data support the upward momentum.

2026-07-02 23:56; UTC

Correlated Moves

EUR/TRY is higher in Thursday's session, supported by a modest increase since Wednesday's close. The pair remains volatile within its one-month range.

2026-07-02 23:56; UTC

ETF Constituents

The Vanguard FTSE Emerging Markets ETF was little changed in after-market hours, with INFY, TCOM, and JD contributing slight declines.

2026-07-02 23:51; UTC

Asia equity markets decline amid semiconductor sell-off, while U.S. indices rise on weak job data easing rate hike fears; European markets gain as defensive sectors lead.

2026-07-02 23:51; UTC

U.S. job growth disappoints with only 57k added in June, prompting reassessment of Fed rate hike expectations, while global markets show mixed signals amid easing inflation concerns.

2026-07-02 23:51; UTC

US equity indices rise as lower-than-expected job growth eases interest rate hike fears, while European markets gain and Asian stocks face losses.

2026-07-02 23:51; UTC

European equity markets rise on positive economic data and easing inflation, with Germany's DAX up 1.9% and Italy's unemployment hitting a record low of 5.0%.

2026-07-02 23:51; UTC

Mexico's Inflation Rate Release on July 9, 2026: Market Eyes Rising Trends Amid Tariff and Oil Price Concerns.

2026-07-02 23:51; UTC

Mexican Inflation Rate Expected to Decline Further Ahead of July 9 Release, Influencing Market Sentiment Amid Global Trends.

2026-07-02 23:51; UTC

Social Media

Fox Corp shares are lower in after-market hours despite record viewership for the U.S. Men's National Team match, averaging 24.43 million viewers.

2026-07-02 23:51; UTC

Fiserv Inc. shares are higher in after-market trading, reflecting positive sentiment following weaker-than-expected job growth data that has eased rate hike concerns.

2026-07-02 23:51; UTC

Macro News
Social Media
ETF Constituents
Correlated Moves

The KOSPI index fell sharply, impacting the iShares MSCI South Korea ETF, which remained near unchanged in after-hours trading.

2026-07-02 23:51; UTC

Lam Research Corp shares are higher in after-market trading, reflecting positive sentiment following a weaker-than-expected jobs report and tempered rate hike fears.

2026-07-02 23:51; UTC

Terra is trading higher today, continuing its upward momentum since Wednesday's close. The asset remains below its 20-day moving average.

2026-07-02 23:51; UTC

PepsiCo Inc shares are lower in after-market hours, with no specific news identified to explain the decline amid generally positive broader market sentiment.

2026-07-02 23:46; UTC

Correlated Moves

J B Hunt Transport Services Inc shares are higher in after-market trading, following a modest increase since Thursday's close amid stable market conditions.

2026-07-02 23:46; UTC

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting a decline since Thursday's close and nearing its one-month low.

2026-07-02 23:46; UTC

Macro News
ETF Constituents
Correlated Moves

Energy Select Sector SPDR Fund declines after-market, influenced by weak U.S. employment data and slight losses among major holdings like Exxon Mobil and Chevron.

2026-07-02 23:42; UTC

U.S. Trade Deficit Expected to Widen to $78.8 Billion in May 2026 Amid Economic Uncertainties and Geopolitical Tensions

2026-07-02 23:42; UTC

U.S. Exports Data Release on July 7 Expected to Reflect Mixed Performance Amid Global Economic Challenges and Tariff Changes

2026-07-02 23:42; UTC

U.S. Imports Data Release on July 7, 2026, Expected to Reflect Strong Growth Amid Tariff Changes and Supply Chain Adjustments

2026-07-02 23:42; UTC

Canada's Trade Surplus Expected to Continue Amid Geopolitical Tensions Ahead of July 7 Data Release

2026-07-02 23:41; UTC

Correlated Moves

NXP Semiconductors NV shares are higher in after-market trading, reflecting a modest increase since Thursday's close amid gains in Skyworks Solutions Inc.

2026-07-02 23:41; UTC

NetApp Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

2026-07-02 23:41; UTC

News
Social Media

Meta shares rise in after-market trading as CEO Zuckerberg highlights upcoming AI benefits and announces new application Pocket, despite some setbacks.

2026-07-02 23:41; UTC

Macro News
Correlated Moves

Bitcoin reached a one-week high today, boosted by weaker U.S. employment data and optimism about Federal Reserve rate hikes. Related stocks also gained.

2026-07-02 23:36; UTC

The US Dollar Index is trading roughly flat amid routine price action. European equity markets closed positively, driven by gains in defensive sectors and pharmaceuticals.

2026-07-02 23:36; UTC

Correlated Moves
Macro News
ETF Constituents

The SPDR S&P Bank ETF is higher after hours, supported by Third Coast Bancshares' $30 million share repurchase program and mixed market performance.

2026-07-02 23:36; UTC

Kraft Heinz Co shares are lower in after-market hours, with no specific news identified to explain the movement. The stock briefly reached a session high earlier.

2026-07-02 23:32; UTC

News
Social Media

Microsoft launches AI initiative Microsoft Frontier Company with $2.5 billion backing. Shares are higher in after-market trading, continuing the broader software sector's upward trend.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

104.82% į viršų

12 mėnesių prognozė

Vidutinis 4.67 USD  104.82%

Aukščiausias 5 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat